The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALIBABA GROUP HLDG LTD | SPONSORED ADS | 01609W102 | 9,114 | 83,770 | SH | SOLE | 1 | 83,770 | 0 | 0 | |
| CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | 2,379 | 37,900 | SH | SOLE | 1 | 37,900 | 0 | 0 | |
| JD.COM INC | SPON ADR CL A | 47215P106 | 7,384 | 127,600 | SH | SOLE | 1 | 127,600 | 0 | 0 | |
| NETEASE INC | SPONSORED ADS | 64110W102 | 3,713 | 41,400 | SH | SOLE | 1 | 41,400 | 0 | 0 | |
| NETFLIX INC | COM | 64110L106 | 2,997 | 8,000 | SH | SOLE | 1 | 8,000 | 0 | 0 | |